Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,251 across all filing types
Latest filing 2018-11-22 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
关于收到上海证券交易所《关于对江西昌九生物化工股份有限公司控制权可能变动事项的问询函》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding a regulatory inquiry letter received from the Shanghai Stock Exchange about a possible change in control of the company. It details questions about a share transfer agreement, pricing rationale, financial status of the acquiring party, and requests for disclosure of risks and insider trading information. The document is a regulatory announcement responding to a regulatory body inquiry and does not contain financial statements, audit results, or detailed financial data. It is not a report itself but a regulatory filing related to compliance and disclosure obligations.
2018-11-22 Chinese
关于对上海证券交易所监管工作函的回复公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Jiangxi Changjiu Biochemical Co., Ltd. responding to a regulatory inquiry from the Shanghai Stock Exchange regarding abnormal stock price fluctuations and the company's ongoing major matter planning, specifically about a control rights transfer and related negotiations. It includes detailed disclosures about the company's and controlling shareholder's actions, risk warnings to investors, and commitments to comply with disclosure requirements. The document does not contain financial statements or detailed financial analysis but is a regulatory response and update on a significant corporate event. It fits best under Regulatory Filings (RNS) as it is a compliance and disclosure announcement responding to a regulatory inquiry rather than a financial report or other specific filing type.
2018-11-22 Chinese
关于控股股东签署股份转让意向协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Jiangxi Changjiu Biochemical Co., Ltd. regarding the signing of a share transfer intention agreement by the controlling shareholder. It details the parties involved, the share transfer terms, due diligence, exclusivity period, breach liabilities, and potential change in control. The document is a formal announcement about a potential change in control due to a share transfer agreement, which is a capital or ownership structure update. It is not a full financial report, audit, or earnings release, nor is it a regulatory certification or voting result. The content fits best under Capital/Financing Update (CAP) as it concerns a significant share transfer and potential control change. The document length is 2496 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is CAP with high confidence.
2018-11-22 Chinese
相关风险提示公告
Regulatory Filings Classification · 95% confidence The document is a risk warning announcement from the board of Jiangxi Changjiu Biochemical Co., Ltd. It discusses abnormal stock price fluctuations, potential major asset restructuring plans under preliminary discussion, and operational risks. It does not contain financial statements or detailed financial data but rather serves as a disclosure of risk factors and ongoing investigations as required by the Shanghai Stock Exchange. The document length is short (1684 characters) and is an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and risk disclosure.
2018-11-21 Chinese
关于收到上海证券交易所《关于江西昌九生物化工股份有限公司筹划重大事项的监管工作函》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding receipt of a regulatory work letter from the Shanghai Stock Exchange about the company's planning of a major matter potentially involving a significant asset restructuring. It includes instructions from the exchange about stock price fluctuations, disclosure requirements, and requests for a written reply. The document is short (881 characters) and primarily a regulatory communication rather than a financial report or detailed filing. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It is a regulatory announcement about compliance and disclosure obligations related to a major corporate event. Therefore, it fits best under Regulatory Filings (RNS).
2018-11-20 Chinese
江西昌九集团有限公司关于上市公司股票异常波动的回复
Regulatory Filings Classification · 95% confidence The document is a response regarding an investigation into abnormal stock price fluctuations of a listed company. It mentions the company is planning a major matter possibly involving a significant asset restructuring, but details are not yet determined. It also states that directors and senior management did not trade shares during the period. The document is short (244 characters) and serves as a regulatory update or announcement rather than a full report or detailed financial disclosure. It does not contain financial statements or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-11-20 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.